1984
DOI: 10.1111/j.1476-5381.1984.tb10145.x
|View full text |Cite
|
Sign up to set email alerts
|

A comparison of dimaprit, nordimaprit, methylamine and chloroquine as inhibitors of mitogen‐induced lymphocyte activation

Abstract: Methylamine and chloroquine both ‘lysosomotropic’ agents (i.e. agents which sequester in lysosomes) caused a dose‐related inhibition of mitogen‐induced lymphocyte activation in the concentrations which have previously been shown to increase the pH of lysosomes. The dose‐response curves of inhibition of mitogen‐induced lymphocyte activation for chloroquine and methylamine are very steep and are similar to the dose‐response curves obtained with dimaprit and nordimaprit, but very different from the flat dose‐resp… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
2
0

Year Published

1988
1988
2012
2012

Publication Types

Select...
4
1
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 17 publications
1
2
0
Order By: Relevance
“…Chloroquine is an antimalarial commonly used as an adjunct agent in SLE maintenance therapy 8 . Inhibition of T lymphocyte mitogenesis was shown in previous studies 39 . However, the current study shows that chloroquine inhibits T lymphocyte proliferation in human whole blood in a concentration‐dependent manner and determines the sensitivity (IC 50 ) of pharmacologic response.…”
Section: Discussionsupporting
confidence: 46%
See 1 more Smart Citation
“…Chloroquine is an antimalarial commonly used as an adjunct agent in SLE maintenance therapy 8 . Inhibition of T lymphocyte mitogenesis was shown in previous studies 39 . However, the current study shows that chloroquine inhibits T lymphocyte proliferation in human whole blood in a concentration‐dependent manner and determines the sensitivity (IC 50 ) of pharmacologic response.…”
Section: Discussionsupporting
confidence: 46%
“…8 Inhibition of T lymphocyte mitogenesis was shown in previous studies. 39 However, the current study shows that chloroquine inhibits T lymphocyte proliferation in human whole blood in a concentration-dependent manner and determines the sensitivity (IC 50 ) of pharmacologic response. This agent showed no interaction with prednisolone in the present study and displayed an additive effect.…”
Section: Discussionmentioning
confidence: 64%
“…It does not bind to DNA by the classic intercalation model, but rather it appears that the small aromatic ring systems can insert between DNA base pairs and induce a bend in the double helix. 102 Chloroquine has been demonstrated to have the following effects: (1) prostaglandin antagonistic effects in the closure of the patent ductus arteriosus and alteration of the biosynthesis of prostaglandins in rabbit peritoneum; 103,104 (2) inhibition of lysosomal enzyme release; 98,105 (3) suppression of the early activation and differentiation of B-cells and therefore suppression of the generation of immunoglobulin secreting cells; 106 (4) inhibition of release of interleukin-1 by monocytes; 107 (5) inhibition of beta-hexosaminidase synthesis and enhancement of excretion of old and newly synthesized enzyme from fibroblasts; 108 (6) significant inhibition of nucleic acid and protein synthesis in rabbit retina; 109 (7) inhibition of membrane phospholipase A 2 of intact neutrophils; 110 and (8) suspected inhibition of fibroblast growth in vitro. 111 When using hydroxychloroquine on patients with CILD, it is often difficult to determine when a sufficient (and effective) dose of medication has been given.…”
Section: Hydroxychloroquinementioning
confidence: 99%